Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Weir: Five stages of evolving beta-cell dysfunction during progression to diabetes. (0.11 sec) 

Five stages of evolving beta-cell dysfunction during progression to diabetes

- diabetesjournals.org
GC Weir, S Bonner-Weir - Diabetes, 2004 - Am Diabetes Assoc
This article proposes five stages in the progression of diabetes, each of which is characterized
by different changes in ß-cell mass, phenotype, and function. Stage 1 is compensation: insulin
secretion increases to maintain normoglycemia in the face of insulin resistance and/or ...
Cited by 162 - Related articles - BL Direct - All 5 versions

Critical reduction in beta-cell mass results in two distinct outcomes over time. …


DR Laybutt, M Glandt, G Xu, YB Ahn, N Trivedi, S … - Journal of Biological …, 2003 - ASBMB
We have proposed that hyperglycemia-induced dedifferentiation of -cells is a critical factor for
the loss of insulin secretory function in diabetes. Here we examined the effects of the duration
of hyperglycemia on gene expression in islets of partially pancreatectomized (Px) rats. ...
Cited by 69 - Related articles - BL Direct - All 4 versions

Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic …


MY Donath, PA Halban - Diabetologia, 2004 - Springer
Increasing evidence indicates that decreased functional beta-cell mass is the hallmark of both
Type 1 and Type 2 diabetes. This underlies the absolute or relative insu- lin insufficiency in both
conditions. In this For Debate, we consider the possible mechanisms responsible for beta- ...
Cited by 123 - Related articles - BL Direct - All 6 versions

Type 2 Diabetes-a Matter of {beta}-Cell Life and Death?

- sciencesignaling.org
CJ Rhodes - Science Signaling, 2005 - sciencesignaling.org
Abstract: In type 2 diabetes, the ß cells of the pancreas fail to produce enough insulin to meet
the body's demand, in part because of an acquired decrease in ß-cell mass. In adults, pancreatic
ß-cell mass is controlled by several mechanisms, including ß-cell replication, neogenesis, ...
Cited by 287 - Related articles - All 13 versions

Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function


S Park, X Dong, TL Fisher, S Dunn, AK Omer, G … - Journal of Biological …, 2006 - ASBMB
The insulin receptor substrate 2 (Irs2) branch of the insulin/insulin-like growth factor-signaling
cascade prevents diabetes in mice because it promotes β cell replication, function, and
survival, especially during metabolic stress. Because exendin-4 (Ex4), a long acting ...
Cited by 65 - Related articles - BL Direct - All 8 versions

Can we make surrogate β-cells better than the original?


GC Weir - Seminars in Cell and Developmental Biology, 2004 - Elsevier
Insufficient pancreatic β-cell mass is fundamental to the pathogenesis of both types 1 and 2 diabetes
and constitutes the basis for the goal of β-cell replacement therapy. Current methods for isolating
islets from organ donor pancreases do not come close to supplying all in need, thus ...
Cited by 15 - Related articles - All 3 versions

Upregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes

- nih.gov
AM Hennige, DJ Burks, U Ozcan, RN … - Journal of Clinical …, 2003 - Am Soc Clin Investig
The insulin receptor substrate-2 (Irs2) branch of the insulin/IGF signaling system coordinates
peripheral insulin action and pancreatic β cell function, so mice lacking Irs2 display similarities
to humans with type 2 diabetes. Here we show that β cell–specific expression of Irs2 at a ...
Cited by 132 - Related articles - BL Direct - All 10 versions

Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% …

- nih.gov [PDF] 
YA Hosokawa, H Hosokawa, C Chen, … - Journal of Clinical …, 1996 - pubmedcentral.nih.gov
Chronic hyperglycemia causes a near-total disappearance of glucose-induced insulin
secretion. To determine if glu- cose potentiation of nonglucose secretagogues is impaired, insulin
responses to 10 9 M glucagonlike peptide–1 (GLP-1) (7–37) were measured at 2.8, 8.3, ...
Cited by 32 - Related articles - BL Direct - All 7 versions

Selective {beta}-Cell Loss and {alpha}-Cell Expansion in Patients with Type 2 …

- endojournals.org
KH Yoon, SH Ko, JH Cho, JM Lee, YB Ahn, KH … - Journal of Clinical …, 2003 - Endocrine Soc
In the presence of obesity, ß-cell mass needs to be increased to compensate for the accompanying
demands and maintain euglycemia. However, in Korea, the majority of type 2 diabetic patients
are nonobese. We determined the absolute masses, relative volumes, and ratio of - and ß- ...
Cited by 179 - Related articles - BL Direct - All 4 versions

Regulation of pancreatic beta-cell mass

- physiology.org
L Bouwens, I Rooman - Physiological reviews, 2005 - Am Physiological Soc
Beta-cell mass regulation represents a critical issue for understanding diabetes, a disease characterized
by a near-absolute (type 1) or relative (type 2) deficiency in the number of pancreatic beta
cells. The number of islet beta cells present at birth is mainly generated by the ...
Cited by 118 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google